---
title: Catalent vs WuXi Advanced Therapies
slug_a: catalent
slug_b: wuxi-advanced-therapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/catalent/wuxi-advanced-therapies
generated_by: BioBM Editorial AI
---

# Catalent vs WuXi Advanced Therapies

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Catalent (catalent) is listed for cdmo. Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.

Services: 32. Modalities: 6. Indications: 0. Locations: 12. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (32).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

WuXi Advanced Therapies (wuxi-advanced-therapies) is listed for cdmo. Cell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.

Services: 15. Modalities: 6. Indications: 0. Locations: 14. Certifications: 6. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (15).

Review summary: Review summary withheld until site-level review gate opens.